72 Although there was a decrease in major bleeding events (absolute difference, −0.63%; HR: 0.46; 95% CI: 0.23-0.94), CV events still showed an increasing trend (absolute difference, 0.90%; HR: 1.50; 95% CI: 0.99-2.26).
← all excerpts
Position Statement on Antiplatelet Therapy for East Asians With Coronary Artery Disease: 2025 Update.
1
—
—